comparemela.com

Latest Breaking News On - Transgene euronext - Page 1 : comparemela.com

Transgene's Combined General Meeting of May 15, 2024

Transgene's Combined General Meeting of May 15, 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

France
Illkirch-graffenstaden
Alsace
Lucie-larguier
Sylvie-berrebi
Frazer-hall
Alessandro-riva
Transgene-euronext
Sandrine-flory
Carol-stuckley
Marie-landel
Siparex-sigefi

Transgene's Combined General Meeting of May 15, 2024 | 15.05.24

Transgene's Combined General Meeting of May 15, 2024 | 15.05.24
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

France
Illkirch-graffenstaden
Alsace
Sylvie-berrebi
Marie-landel
Siparex-sigefi
Philippe-archinard
Lucie-larguier
Frazer-hall
Fondation-solidarit
Transgene-euronext
Sandrine-flory

Transgene provides business and financial update for Q1 2024

Transgene provides business and financial update for Q1 2024
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

France
Transgene-euronext
Lucie-larguier
Frazer-hall-sylvie-berrebi
Linkedin
Twitter
Euronext-paris
Artificial-intelligence
Risk-factors
Universal-registration-document

Availability of Preparatory Documents for the Combined General Meeting of May 15, 2024

Strasbourg, France, April 24, 2024, 5:45 p.m. CET - Transgene , a biotech company that designs and develops virus-based immunotherapies, announced that the documentation related to the Combined.

France
Sylvie-berrebi-frazer-hall
Transgene-euronext
Lucie-larguier
Twitter
Linkedin
Euronext-paris
Combined-general-meeting
General-meeting
Artificial-intelligence
Risk-factors
Universal-registration-document

Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024

Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
jcnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jcnnewswire.com Daily Mail and Mail on Sunday newspapers.

San-diego
California
United-states
France
Ankara
Turkey
Tokyo
Japan
United-kingdom
American
Christophe-le-tourneau
Institut-curie

vimarsana © 2020. All Rights Reserved.